OFFICE OF CONTINUING MEDICAL EDUCATION

Patient Safety & Quality: An Overview
OR
Behavior Change in Healthcare

Online Course
June 1, 2013 - June 1, 2022


  • Course Description
  • Registration Information

Program (Course) Description

This course discusses the state of current health care and the role of patient safety and quality as a professional responsibility. Included is the definition of quality and an explanation of the quality gap. Furthermore, the principles of quality improvement are explained within the context of medical research. Quality improvement tools and the steps to improve the quality of care delivered are identified. An outline of national patient safety goals and a description of integrated patient safety/risk management programs that promote these goals are included. This lecture also provides examples of sentinel events, close call root cause analysis, healthcare failure mode and effect analysis.

 

Who Should Attend?
This activity is designed for physicians, nurses, pharmacists and administrators.


Learning Objectives
Upon completion of this activity participants will be able to:

  • Describe the quality & patient safety gap
  • Identify quality improvement methods
  • Identify some Joint Commission National Patient Safety Goals
  • Describe influencers and processes associated with promoting patient safety

Physician Participation
Upon completion of viewing the online presentation, please follow the instructions at the end of the presentation to complete the evaluation.  Once the evaluation is completed, the user will be provided the option to print their certificate.


Program Registration Information
Registration Fees
UTHSCSA Faculty $25.00
Non-UTHSCSA $35.00


REGISTER NOW

Continuing Medical Education Credit - Accreditation Statement
UT Health Science Center San Antonio School of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


† This session meets the Texas Medical Board Criteria for formal Continuing Medical Education involving the study of medical ethics and/or professional responsibility.

Release date: June 1, 2013     Credits expire: June 1, 2022


Credit may be otained upon successful completion of the activity evaluation.


Contact
Continuing Medical Education Office
Email: cme@uthscsa.edu
Phone: 1 (866) 601-4448 or (210)567-4491

Hardware/Software Requirements

Windows requirements
  • Microsoft® Windows XP, Windows 2003,Windows Vista®, or Windows 7
  • Microsoft Internet Explorer® 6.0 SP1 or later, Firefox® 2.0 or later, or Google Chrome 1.0
  • Windows Media® Player 9.0 or later
  • Broadband Internet connection (256 Kbps & above)
Mac requirements
  • Apple® Mac® OS X 10.4.8 or later
  • Apple Safari™ 2.0.4 or later or Firefox 2.0 or later
  • Microsoft Silverlight® 2.0 or later
  • Broadband Internet connection (256 Kbps & above)

Faculty/Speaker:

Jan E Patterson, MD, MS

Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality and Lifelong Learning
Director, Center for Patient Safety and Health Policy
Financial Disclosure: Dr. Patterson  has disclosed that she is a consultant/advisor for Rib-X Pharmaceuticals, Inc as well as an investigator for the UT System and IHI. Her spouse, Dr. Thomas Patterson is a consultant/advisor for Basilea, Merck, Pfizer, and Toyoma as well as an investigator for Astellas, Basilea, Merck, and Pfizer. 

 

Content Reviewer:

Craig Klugman, PhD

Associate Professor
Stewart & Marianne Reuter Endowed Professorship in Medical Humanities

Center for Medical Humanities & Ethics

Course Director:


Jan E Patterson, MD, MS

Professor of Medicine/Infectious Diseases and Pathology
Associate Dean for Quality and Lifelong Learning
Director, Center for Patient Safety and Health Policy
Financial Disclosure: Dr. Patterson  has disclosed that she is a consultant/advisor for Rib-X Pharmaceuticals, Inc as well as an investigator for the UT System and IHI. Her spouse, Dr. Thomas Patterson is a consultant/advisor for Basilea, Merck, Pfizer, and Toyoma as well as an investigator for Astellas, Basilea, Merck, and Pfizer. 


Planners:


Leticia Bresnahan, MBA
Senior Project Coordinator
Center for Patient Safety & Health Policy
Financial Disclosure: Ms Bresnahan has no relevant financial relationships to disclose.



REGISTER NOW